Allergy Therapeutics PLC
LSE:AGY

Watchlist Manager
Allergy Therapeutics PLC Logo
Allergy Therapeutics PLC
LSE:AGY
Watchlist
Price: 6.25 GBX -0.79% Market Closed
Market Cap: 297.9m GBX
Have any thoughts about
Allergy Therapeutics PLC?
Write Note

Allergy Therapeutics PLC
Cash Taxes Paid

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Allergy Therapeutics PLC
Cash Taxes Paid Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Taxes Paid CAGR 3Y CAGR 5Y CAGR 10Y
Allergy Therapeutics PLC
LSE:AGY
Cash Taxes Paid
ÂŁ323k
CAGR 3-Years
-34%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
GlaxoSmithKline PLC
LSE:GSK
Cash Taxes Paid
ÂŁ1.5B
CAGR 3-Years
-3%
CAGR 5-Years
2%
CAGR 10-Years
1%
AstraZeneca PLC
LSE:AZN
Cash Taxes Paid
$2.6B
CAGR 3-Years
17%
CAGR 5-Years
22%
CAGR 10-Years
13%
Verona Pharma PLC
NASDAQ:VRNA
Cash Taxes Paid
$279k
CAGR 3-Years
-71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hikma Pharmaceuticals PLC
LSE:HIK
Cash Taxes Paid
$99m
CAGR 3-Years
-9%
CAGR 5-Years
8%
CAGR 10-Years
-1%
Dechra Pharmaceuticals PLC
LSE:DPH
Cash Taxes Paid
ÂŁ27.4m
CAGR 3-Years
29%
CAGR 5-Years
19%
CAGR 10-Years
13%
No Stocks Found

Allergy Therapeutics PLC
Glance View

Market Cap
297.9m GBX
Industry
Pharmaceuticals

Allergy Therapeutics Plc is a biotechnology company. The company is headquartered in Worthing, West Sussex and currently employs 601 full-time employees. The company went IPO on 2004-10-11. The firm is focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines. Its segments include Central Europe, which include segments, such as Germany, Austria, Switzerland and the Netherlands; Southern Europe, which includes Italy, Spain and Other; the United Kingdom, and Rest of World. The company sells both injectable and sublingual allergen-specific immunotherapies. Its pipeline candidates include Grass MATA MPL, Birch MATA MPL, Ragweed MATA MPL, Trees MATA MPL and Peanut SCIT. Its vaccine candidates outside allergy include disease areas, including cancer, asthma, atopic dermatitis and psoriasis. Its products include Pollinex, Pollinex Quattro, Oralvac, Acarovac Plus, Venomil, VLP Peanut and ImmunoBON.

AGY Intrinsic Value
4.33 GBX
Overvaluation 31%
Intrinsic Value
Price

See Also

What is Allergy Therapeutics PLC's Cash Taxes Paid?
Cash Taxes Paid
323k GBP

Based on the financial report for Dec 31, 2023, Allergy Therapeutics PLC's Cash Taxes Paid amounts to 323k GBP.

What is Allergy Therapeutics PLC's Cash Taxes Paid growth rate?
Cash Taxes Paid CAGR 10Y
-2%

Over the last year, the Cash Taxes Paid growth was -24%. The average annual Cash Taxes Paid growth rates for Allergy Therapeutics PLC have been -34% over the past three years , and -2% over the past ten years .

Back to Top